RSS-Feed abonnieren
DOI: 10.1055/s-0038-1651579
Two Independent Binding Sites on Monolayers of Human Endothelial Cells Are Responsible for Interaction with Coagulation Factor VII and Factor VIIa
Autor*innen
Publikationsverlauf
Received 23. Januar 1992
Accepted after revision 23. September 1992
Publikationsdatum:
03. Juli 2018 (online)
Summary
The interaction of radiolabeled factor VII (FVII) and factor VIIa (FVIIa) with endotoxin-stimulated endothelial cells (EC), known to express tissue factor (TF), and unstimulated EC was studied. FVII/FVIIa binding to EC-monolayers was saturable within 4.5-6 h, reversible, temperature and calcium dependent on both, endotoxin-stimulated and on unstimulated EC. Upon 2 h of incubation on EC, FVII was partially converted to FVIIa in the absence of protease inhibitors. The affinity of this binding was K d = 45.4 ± 18.7 nM with a calculated number of binding sites B max = 3.75 ± 0.31 × 106 molecules/cell. In addition to unlabeled FVII and FVIIa, other vitamin K-dependent proteins reduced binding of [125I]-FVII/FVIIa to about 60-70%, and this type of common binding site for vitamin K-dependent proteins revealed a K d = 32.2 ± 5.6 nM and a B max = 3.03 ± 0.14 × 106 molecules/cell. Moreover, in the presence of 1 μM prothrombin to suppress common binding sites, only on endotoxin-stimulated EC additional inhibition of FVII/FVIIa binding was achieved by anti-TF antibodies. The characteristics of the FVII/FVIIa-TF interaction with a K d = 17.2 ± 5.2 nM and a B max = 342,000 ± 1,100 binding sites/cell revealed a similar saturation kinetics in radioligand binding and in functional factor X activation within 90-120 min. These data indicate the presence of at least two independent binding sites for FVII/FVIIa on stimulated EC of which about 10% are TF specific. The existence of binding sites common for vitamin K-dependent proteins on both types of EC may improve the availability of FVII/FVIIa once EC become stimulated and express TF on their surface.
-
References
- 1 Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896
- 2 Brox JH, Osterud B, Björklid E, Fenton JW. Production and availability of thromboplastin in endothelial cells: the effect of thrombin, endotoxin and platelets. Br J Haematol 1984; 57: 239-246
- 3 Rivers RPA, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-316
- 4 Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-745
- 5 Schorer AE, Kaplan ME, Rao GHR, Moldow CF. Interleukin-1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemostas 1986; 56: 256-259
- 6 Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130
- 7 Warr TA, Rao LVM, Rapaport SI. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 1990; 75: 1481-1489
- 8 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemostas 1991; 66: 67-79
- 9 Bach RR. Initiation of coagulation by tissue factor. CRC C R Biochem 1988; 23: 339-368
- 10 Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. J Biol Chem 1989; 264: 20705-20713
- 11 Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 1986; 25: 4007-4020
- 12 Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987; 262: 11692-11698
- 13 Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. J Biol Chem 1989; 264: 9980-9988
- 14 Broze GJ. Binding of human factor VII and VIIa to monocytes. J Clin Invest 1982; 70: 526-535
- 15 Osterud B, Björklid E. Human factor VII associated with endotoxin-stimulated monocytes in whole blood. Biochem Biophys Res Commun 1982; 108: 620-626
- 16 Ruf W, Edgington TS. Two sites in the tissue factor extra-cellular domain mediate the recognition of the ligand factor VIIa. Proc Natl Acad Sci 1991; 88: 8430-8434
- 17 Fraker PJ, Speck Jr JC. Protein and cell membrane iodination with sparingly soluble chloramine, 1,3,4,6-tetrachloro-3a,6a-diphenyl glycouril. Biochem Biophys Res Commun 1978; 80: 849-857
- 18 Preissner KT, Wassmuth R, Müller-Berghaus G. Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J 1985; 231: 349-355
- 19 Preissner KT, Delvos U, Müller-Berghaus G. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism. Biochemistry 1987; 26: 2521-2528
- 20 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
- 21 Tanaka H, Janssen B, Preissner KT, Müller-Berghaus G. Purification of glycosylated apoprotein of tissue factor from human brain and inhibition of its procoagulant activity by a specific antibody. Thromb Res 1985; 40: 745-756
- 22 Born VJJ, Ram IE, Alderkamp GHJ, Reinaldapoot HH, Bertina RM. Application of factor VII-sepharose affinity chromatography in purification of human tissue factor apoprotein. Thromb Res 1986; 42: 635-643
- 23 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756
- 24 Klagsbrun M, Sullivan R, Smith S, Rybka R, Shing Y. Purification of endothelial cell growth factors by heparin affinity chromatography. Methods Enzymol 1987; 147: 95-105
- 25 Wroblewski F, LaDue JS. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955; 90: 210-215
- 26 Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660-672
- 27 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
- 28 Merill CR, Switzer RC, Van Keuren ML. Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and highly sensitive silver stain. Proc Natl Acad Sci USA 1979; 76: 4335-4339
- 29 Ploplis VA, Edgington TS, Fair DS. Initiation of the extrinsic pathway of coagulation. J Biol Chem 1987; 262: 9503-9508
- 30 Sakai T, Kisiel W. Binding of human factor X and Xa to HepG2 and J82 human tumor cell lines. Evidence that FXa binds to tumor cells independent of factor Va. J Biol Chem 1990; 265: 9105-9113
- 31 Heimark RL, Schwartz SM. Binding of coagulation factor IX and X to the endothelial cell surface. Biochem Biophys Res Commun 1983; 111: 723-731
- 32 Rodgers GM, Shuman MA. Characterisation of the interaction between factor Xa and bovine aortic endothelial cells. Biochim Biophys Acta 1985; 844: 320-329
- 33 Stern MS, Nawroth PP, Kisiel W, Vehar G, Esmon CT. The binding of factor IXa to cultured bovine endothelial cells. J Biol Chem 1985; 260: 6717-6722
- 34 Ruf W, Rehemtulla A, Edgington TS. Phospholipid-independent and dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 265: 2158-2166
- 35 Toomey JR, Smith KJ, Stafford DW. Localization of the human tissue factor recognition determinant of human factor VIIa. J Biol Chem 1991; 266: 19198-19202
- 36 Ruf W, Kalnik MW, Lund-Hansen T, Edgington TS. Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions. J Biol Chem 1991; 266: 15719-15725
- 37 Sakai T, Lund-Hansen T, Thim L, Kisiel W. The ϒ-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor. J Biol Chem 1990; 265: 1890-1894
- 38 Rodgers GM, Broze Jr GJ, Shuman MA. The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood 1984; 63: 434-438
- 39 Nemerson Y, Repke D. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofactor. Thromb Res 1985; 40: 351-358
- 40 Rao LVM, Rapaport SI. Activation of factor VII bound to tissue factor: A key early step in the tissue factor pathway of coagulation. Proc Natl Acad Sci USA 1988; 85: 6687-6691
- 41 Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 1988; 71: 335-343
- 42 Warn-Cramer BJ, Almus FE, Rapaport SI. Studies on the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells. Thromb Haemostas 1989; 61: 101-105